Features of the myocardial infarction course in patients with a permanent atrial fibrillation.

M. I. Yalovenko, O. O. Khaniukov

Abstract


Atrial fibrillation (AF) is the most common cardiac arrhythmias in the population. Nowadays, AF is regarded as potentially lethal arrhythmia, considering the broad range of its negative consequences, not only due to significant deterioration in the quality of the patients’ life, but also due to related significant increase in the incidence of serious complications and death. The presence of permanent AF is associated with a twofold increase in the risk of myocardial infarction (MI) development. The purpose of the research is to study the features of the MI course, the condition of intracardiac hemodynamics, the volume of the cardiac muscle injury in patients with a permanent AF. It was done a retrospective study of 1145 patients’ case histories who were undergoing in-patient treatment for the acute MI on the basis of the CI "Dnipropetrovsk Clinical Association of Emergency Medical Aid". The first group included 134 patients with acute MI without concomitant heart rhythm disorders. The second group consisted of 102 patients with acute MI which arose on the background of a permanent form of AF. The groups were comparable in age and gender. The presence of permanent AF was associated with prognosis deterioration, early hospital mortality in patients with acute MI due to progression of heart failure, development of acute left ventricular insufficiency. A larger amount of myocardial necrosis was observed in patients with permanent AF compared to those with sinus rhythm. Conclusion: the presence of permanent AF impairs the course of acute MI, increases the risk of early hospital mortality, which requires a personalized approach to the management of patients with a permanent AF for preventing the risk of MI developing and thromboembolic complications.


Keywords


acute myocardial infarction; atrial fibrillation; complication; prognosis

References


Dzyak GV, Zharіnov OY. [Atrial fibrillation]. Chetverta khvilya. 2011;192. Ukrainian.

Boriani G, Laroche C, Diemberger I. Asympto­matic atrial fibrillation: clinical correlates, ma­nagement, and outcomes in the EORP-AF Pilot Ge­neral Registry. American Journal of Medicine. 2015;128:50-4.

Freedman B, Lowres S. Asymptomatic atrial fib­rillation: the case for screening to prevent stroke. JAMA. 2015;314:1911-12.

Harada M,Wagoner V, Nattel S. Role of inflam­mation in atrial fibrillation pathophysiology and management. Circulation. 2015;79:495-02.

Healey J, Oldgren К, Ezekowitz M. Occurrence of death and stroke in patients in 47 countries 1 year after pre­senting with atrial fibrillation: a cohort study. Circulation. 2016;388:1161-69.

Lang R, Badano LP, Mor-Avi V, еt al. Recom­mendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the Ame­rican Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echo­cardiogr. 2015;28:1440-57.

Mozaffarian D, Benjamin J, Arnett D. Heart di­sease and stroke statistics-2016 update: a report from the Ame­rican Heart Association. Circulation. 2016;133:356-60.

Andrade J, Khairy P, Dobrev D, Nattel S. The cli­nical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circulation. 2014;114:1453-68.


GOST Style Citations


  1. Дзяк Г.В. Фібриляція передсердь / Г.В. Дзяк, О.Й. Жарінов. – Київ: Четверта хвиля, 2011. – 192 с.
  2. Boriani G. Asymptomatic atrial fibrillation: clini­cal correlates, management, and outcomes in the EORP-AF Pilot General Registry / G. Boriani, C. Laroche, I. Diemberger // Am. J. Medicine. – 2015. – Vol. 128. – P. 50.
  3. Freedman B. Asymptomatic atrial fibrillation: the case for screening to prevent stroke / B. Freedman,S. Lowres// JAMA. – 2015. – Vol. 314. – P. 1911–1912.
  4. Harada M. Role of inflammation in atrial fibril­lation pathophysiology and management / M. Harada, V. Wagoner, S. Nattel // Circulation. – 2015. – Vol. 79. – P. 495-502.
  5. Healey J. Occurrence of death and stroke in pa­tients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study / J. Healey, K. Oldgren, M. Ezekowitz // Circulation. – 2016. – Vol. 388. – P. 1161-1169.
  6. Lang R. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Up­date from the American Society of Echocardiography and the European Association of Cardiovascular Imaging / R. Lang, L. Badano, V. Mor-Avi. // J. Am. Soc. Echo­car­diogr. – 2015. – Vol. 28. – P. 1440-1457.
  7. Mozaffarian D. Heart disease and stroke sta­tistics-2016 update: a report from the American Heart Association / D. Mozaffarian, J. Benjamin, D. Arnett // Circulation. – 2016. – Vol. 133. – P. 356-360.
  8. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epi­demiology, and mechanisms / J. Andrade, P. Khairy, D. Dob­rev, S. Nattel // Circulation. – 2014. – Vol. 114. – P.  453-1468.




DOI: https://doi.org/10.26641/2307-0404.2018.2(part1).129518

Refbacks

  • There are currently no refbacks.